{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:42:48Z","timestamp":1792086168642,"version":"4.4.0"},"reference-count":90,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2019.0435","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T11:47:23Z","timestamp":1560426443000},"source":"Crossref","is-referenced-by-count":30,"title":["Toxoplasmosis in Germany: Epidemiology, Diagnosis, Risk Factors, and Treatment"],"prefix":"10.3238","author":[{"given":"Uwe","family":"Pleyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Wilking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"10.3238\/arztebl.2019.0435_ref1","doi-asserted-by":"crossref","unstructured":"Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet 2004; 363: 1965\u201376","DOI":"10.1016\/S0140-6736(04)16412-X"},{"key":"10.3238\/arztebl.2019.0435_ref2","doi-asserted-by":"crossref","unstructured":"Havelaar AH, Kirk MD, Torgerson PR, et al.: World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med 2015; 12: e1001923","DOI":"10.1371\/journal.pmed.1001923"},{"key":"10.3238\/arztebl.2019.0435_ref3","doi-asserted-by":"crossref","unstructured":"Schl\u00fcter D, D\u00e4ubener W, Schares G, Gro\u00df U, Pleyer U, L\u00fcder C: Animals are key to human toxoplasmosis. Int J Med Microbiol 2014; 304: 917\u201329","DOI":"10.1016\/j.ijmm.2014.09.002"},{"key":"10.3238\/arztebl.2019.0435_ref4","doi-asserted-by":"crossref","unstructured":"Torgerson PR, Mastroiacovo P: The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 2013; 91: 501\u20138","DOI":"10.2471\/BLT.12.111732"},{"key":"10.3238\/arztebl.2019.0435_ref5","doi-asserted-by":"crossref","unstructured":"Wilking H, Thamm M, Stark K, Aebischer T, Seeber F: Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep 2016; 6: 22551","DOI":"10.1038\/srep22551"},{"key":"10.3238\/arztebl.2019.0435_ref6","unstructured":"Robert Koch-Institut: RKI-Ratgeber Toxoplasmose ."},{"key":"10.3238\/arztebl.2019.0435_ref7","doi-asserted-by":"crossref","unstructured":"Fernandez C, Jaimes J, Ortiz MC, Ramirez JD: Host and Toxoplasma gondii genetic and non-genetic factors influencing the development of ocular toxoplasmosis: a systematic review. Infect Genet Evol 2016; 44: 199\u2013209","DOI":"10.1016\/j.meegid.2016.06.053"},{"key":"10.3238\/arztebl.2019.0435_ref8","doi-asserted-by":"crossref","unstructured":"Rodrigues KF, Faria e Arantes TE, Muccioli C, Neto JL, Pinheiro MM: Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNF-alpha blockers. Parasitol Int 2013; 62: 272\u20135","DOI":"10.1016\/j.parint.2013.02.003"},{"key":"10.3238\/arztebl.2019.0435_ref9","doi-asserted-by":"crossref","unstructured":"Rico-Torres CP, Vargas-Villavicencio JA, Correa D: Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis 2016; 35: 1079\u201388","DOI":"10.1007\/s10096-016-2656-2"},{"key":"10.3238\/arztebl.2019.0435_ref10","doi-asserted-by":"crossref","unstructured":"Herrmann DC, Maksimov P, Hotop A, et al.: Genotyping of samples from German patients with ocular, cerebral and systemic toxoplasmosis reveals a predominance of Toxoplasma gondii type II. Int J Med Microbiol 2014; 304: 911\u20136","DOI":"10.1016\/j.ijmm.2014.06.008"},{"key":"10.3238\/arztebl.2019.0435_ref11","doi-asserted-by":"crossref","unstructured":"Vallochi AL, Muccioli C, Martins MC, Silveira C, Belfort R, Rizzo LV: The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 2005; 139: 350\u20131","DOI":"10.1016\/j.ajo.2004.07.040"},{"key":"10.3238\/arztebl.2019.0435_ref12","doi-asserted-by":"crossref","unstructured":"Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A: HLA typing in congenital toxoplasmosis. Br J Ophthalmol 1995; 79: 494\u20137","DOI":"10.1136\/bjo.79.5.494"},{"key":"10.3238\/arztebl.2019.0435_ref13","doi-asserted-by":"crossref","unstructured":"Luma HN, Tchaleu BC, Mapoure YN, et al.: Toxoplasma encephalitis in HIV\/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study. BMC Res Notes 2013; 6: 146","DOI":"10.1186\/1756-0500-6-146"},{"key":"10.3238\/arztebl.2019.0435_ref14","doi-asserted-by":"crossref","unstructured":"Garweg JG, Scherrer JN, Halberstadt M: Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol 2008; 92: 1253\u20136","DOI":"10.1136\/bjo.2007.123661"},{"key":"10.3238\/arztebl.2019.0435_ref15","doi-asserted-by":"crossref","unstructured":"El Bissati K, Levigne P, Lykins J, et al.: Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect 2018; 7: 165","DOI":"10.1038\/s41426-018-0164-4"},{"key":"10.3238\/arztebl.2019.0435_ref16","doi-asserted-by":"crossref","unstructured":"Maenz M, Schl\u00fcter D, Liesenfeld O, Schares G, Gro\u00df U, Pleyer U: Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res 2014; 39: 77\u2013106","DOI":"10.1016\/j.preteyeres.2013.12.005"},{"key":"10.3238\/arztebl.2019.0435_ref17","doi-asserted-by":"crossref","unstructured":"Parlog A, Schluter D, Dunay IR: Toxoplasma gondii-induced neuronal alterations. Parasite Immunol 2015; 37: 159\u201370","DOI":"10.1111\/pim.12157"},{"key":"10.3238\/arztebl.2019.0435_ref18","doi-asserted-by":"crossref","unstructured":"Elbez-Rubinstein A, Ajzenberg D, Darde ML, et al.: Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 2009; 199: 280\u20135","DOI":"10.1086\/595793"},{"key":"10.3238\/arztebl.2019.0435_ref19","doi-asserted-by":"crossref","unstructured":"Thiebaut R, Leproust S, Chene G, Gilbert R: Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients\u2018 data. Lancet 2007; 369: 115\u201322","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"10.3238\/arztebl.2019.0435_ref20","doi-asserted-by":"crossref","unstructured":"Villena I, Ancelle T, Delmas C, et al.: Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010; 15","DOI":"10.2807\/ese.15.25.19600-en"},{"key":"10.3238\/arztebl.2019.0435_ref21","doi-asserted-by":"crossref","unstructured":"de-la-Torre A, Rios-Cadavid AC, Cardozo-Garcia CM, Gomez-Marin JE: Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia. Br J Ophthalmol 2009; 93: 1001\u20134","DOI":"10.1136\/bjo.2008.155861"},{"key":"10.3238\/arztebl.2019.0435_ref22","doi-asserted-by":"crossref","unstructured":"Holland GN, Crespi CM, ten Dam-van Loon N, et al.: Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 2008; 145: 1007\u201313","DOI":"10.1016\/j.ajo.2008.01.023"},{"key":"10.3238\/arztebl.2019.0435_ref23","doi-asserted-by":"crossref","unstructured":"Robert-Gangneux F, Meroni V, Dupont D, et al.: Toxoplasmosis in transplant recipients, Europe, 2010\u20132014. Emerg Infect Dis 2018; 24: 1497\u2013504","DOI":"10.3201\/eid2408.180045"},{"key":"10.3238\/arztebl.2019.0435_ref24","doi-asserted-by":"crossref","unstructured":"Prestes DP, Mendes C, Batista MV, et al.: A case-series of Toxoplasmosis in hematopoietic stem cell transplantation: still a concern for endemic countries. Bone Marrow Transplant. 2018;5:1336\u20139","DOI":"10.1038\/s41409-018-0179-4"},{"key":"10.3238\/arztebl.2019.0435_ref25","doi-asserted-by":"crossref","unstructured":"Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC: Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691\u20138","DOI":"10.1038\/sj.bmt.1703425"},{"key":"10.3238\/arztebl.2019.0435_ref26","doi-asserted-by":"crossref","unstructured":"Isa F, Saito K, Huang YT, et al.: Implementation of molecular surveillance after a cluster of fatal toxoplasmosis at 2 neighboring transplant centers. Clin Infect Dis 2016; 63: 565\u20138","DOI":"10.1093\/cid\/ciw330"},{"key":"10.3238\/arztebl.2019.0435_ref27","doi-asserted-by":"crossref","unstructured":"Ullmann AJ, Schmidt-Hieber M, Bertz H, et al.: Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol 2016; 95: 1435\u201355","DOI":"10.1007\/s00277-016-2711-1"},{"key":"10.3238\/arztebl.2019.0435_ref28","doi-asserted-by":"crossref","unstructured":"Silva AC, Rodrigues BS, Micheletti AM, et al.: Neuropathology of AIDS: an autopsy review of 284 cases from Brazil comparing the findings pre- and post-HAART (Highly Active Antiretroviral Therapy) and pre- and postmortem correlation. AIDS Res Treat 2012; 2012: 186850","DOI":"10.1155\/2012\/186850"},{"key":"10.3238\/arztebl.2019.0435_ref29","doi-asserted-by":"crossref","unstructured":"Ford N, Meintjes G, Calmy A, et al.: Managing advanced HIV disease in a public health approach. Clin Infect Dis 2018; 66: 106\u201310","DOI":"10.1093\/cid\/cix1139"},{"key":"10.3238\/arztebl.2019.0435_ref30","doi-asserted-by":"crossref","unstructured":"Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H: Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol 2016; 32: 492\u2013506","DOI":"10.1016\/j.pt.2016.04.001"},{"key":"10.3238\/arztebl.2019.0435_ref31","doi-asserted-by":"crossref","unstructured":"Pomares C, Montoya JG: Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol 2016; 54: 2448\u201354","DOI":"10.1128\/JCM.00487-16"},{"key":"10.3238\/arztebl.2019.0435_ref32","doi-asserted-by":"crossref","unstructured":"Gro\u00df U, L\u00fcder CG, Hendgen V, et al.: Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J Clin Microbiol 2000; 38: 3619\u201322.","DOI":"10.1128\/JCM.38.10.3619-3622.2000"},{"key":"10.3238\/arztebl.2019.0435_ref33","doi-asserted-by":"crossref","unstructured":"Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F: Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol 2010; 48: 41\u20135","DOI":"10.1128\/JCM.01903-09"},{"key":"10.3238\/arztebl.2019.0435_ref34","doi-asserted-by":"crossref","unstructured":"Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M: Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect 2015; 21: 191.e1\u20138","DOI":"10.1016\/j.cmi.2014.09.018"},{"key":"10.3238\/arztebl.2019.0435_ref35","doi-asserted-by":"crossref","unstructured":"Hotop A, Hlobil H, Gro\u00df U: Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2012; 54: 1545\u201352","DOI":"10.1093\/cid\/cis234"},{"key":"10.3238\/arztebl.2019.0435_ref36","doi-asserted-by":"crossref","unstructured":"Villard O, Cimon B, L\u2018Ollivier C, et al.: Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 2016; 84: 22\u201333","DOI":"10.1016\/j.diagmicrobio.2015.09.009"},{"key":"10.3238\/arztebl.2019.0435_ref37","unstructured":"Mandelbrot L, Kieffer F, Sitta R, et al.: Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol 2018; 219: 386.e1\u2013.e9."},{"key":"10.3238\/arztebl.2019.0435_ref38","doi-asserted-by":"crossref","unstructured":"Kijlstra A, Jongert E: Toxoplasma-safe meat: close to reality? Trends in Parasitology 2009; 25: 18\u201322","DOI":"10.1016\/j.pt.2008.09.008"},{"key":"10.3238\/arztebl.2019.0435_ref39","unstructured":"Richtlinien des Gemeinsamen Bundesausschusses \u00fcber die \u00e4rztliche Betreuung w\u00e4hrend der Schwangerschaft und nach der Entbindung. Bundesanzeiger 2016: 60a. www.g-ba.de\/richtlinien\/19\/"},{"key":"10.3238\/arztebl.2019.0435_ref40","doi-asserted-by":"crossref","unstructured":"Lange AE, Thyrian JR, Wetzka S, et al.: The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study. BMC Pregnancy Childbirth 2016; 16: 197","DOI":"10.1186\/s12884-016-0966-0"},{"key":"10.3238\/arztebl.2019.0435_ref41","doi-asserted-by":"crossref","unstructured":"Cassini A, Colzani E, Pini A, et al.: Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill 2018; 23: 17\u201300454","DOI":"10.2807\/1560-7917.ES.2018.23.16.17-00454"},{"key":"10.3238\/arztebl.2019.0435_ref42","doi-asserted-by":"crossref","unstructured":"Suijkerbuijk AWM, van Gils PF, Bonacic Marinovic AA, et al.: The design of a social cost-benefit analysis of preventive interventions for toxoplasmosis: an example of the One Health approach. Zoonoses Public Health 2018; 65: 185\u201394","DOI":"10.1111\/zph.12417"},{"key":"10.3238\/arztebl.2019.0435_ref43","unstructured":"da Silva AJ, Moser M: Toxoplasmosis. Image #3421 i; Centers for Disease Control and Prevention\u2018s Public Health Image Library 2002. https:\/\/phil.cdc.gov\/Details.aspx?pid=3421 (last accessed on 19 May 2019)."},{"key":"10.3238\/arztebl.2019.0435_ref44","doi-asserted-by":"crossref","unstructured":"Bowie WR, King AS, Werker DH, et al.: Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997; 350: 173\u20137","DOI":"10.1016\/S0140-6736(96)11105-3"},{"key":"10.3238\/arztebl.2019.0435_ref45","doi-asserted-by":"crossref","unstructured":"Jones JL, Dubey JP: Waterborne toxoplasmosis \u2013 recent developments. Exp Parasitol 2010; 124: 10\u201325","DOI":"10.1016\/j.exppara.2009.03.013"},{"key":"10.3238\/arztebl.2019.0435_ref46","doi-asserted-by":"crossref","unstructured":"Lass A, Szostakowska B, Korzeniewski K, Karanis P: The first detection of Toxoplasma gondii DNA in environmental air samples using gelatine filters, real-time PCR and loop-mediated isothermal (LAMP) assays: qualitative and quantitative analysis. Parasitology 2017; 144: 1791\u2013801","DOI":"10.1017\/S0031182017001172"},{"key":"10.3238\/arztebl.2019.0435_ref47","doi-asserted-by":"crossref","unstructured":"Robert-Gangneux F, Darde ML: Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25: 264\u201396","DOI":"10.1128\/CMR.05013-11"},{"key":"10.3238\/arztebl.2019.0435_ref48","doi-asserted-by":"crossref","unstructured":"Bremer v, Bocter N, Rehmet S, Klein G, Breuer T, Ammon A: Consumption, knowledge, and handling of raw meat: a representative cross-sectional survey in Germany, March 2001. J Food Prot 2005; 68: 785\u20139","DOI":"10.4315\/0362-028X-68.4.785"},{"key":"10.3238\/arztebl.2019.0435_ref49","doi-asserted-by":"crossref","unstructured":"Rosner BM, Stark K, H\u00f6hle M, Werber D: Risk factors for sporadic Yersinia enterocolitica infections, Germany 2009\u20132010. Epidemiol Infect 2012; 140: 1738\u201347","DOI":"10.1017\/S0950268811002664"},{"key":"10.3238\/arztebl.2019.0435_ref50","doi-asserted-by":"crossref","unstructured":"Xiao J, Yolken RH: Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases. Acta Physiol (Oxf) 2015; 213: 828\u201345","DOI":"10.1111\/apha.12458"},{"key":"10.3238\/arztebl.2019.0435_ref51","doi-asserted-by":"crossref","unstructured":"Gonzalez-Vicent M, Diaz MA, Sevilla J, Madero L: Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT). Ann Hematol 2003; 82: 649\u201353","DOI":"10.1007\/s00277-003-0705-2"},{"key":"10.3238\/arztebl.2019.0435_ref52","doi-asserted-by":"crossref","unstructured":"Lassoued S, Zabraniecki L, Marin F, Billey T: Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum 2007; 36: 262\u20133","DOI":"10.1016\/j.semarthrit.2006.08.004"},{"key":"10.3238\/arztebl.2019.0435_ref53","unstructured":"Desmonts G, Couvreur J: [Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]. Ann Pediatr (Paris) 1984; 31: 805\u20139."},{"key":"10.3238\/arztebl.2019.0435_ref54","doi-asserted-by":"crossref","unstructured":"V\u00f6kt CA, Visca E, Tercanli S: Sonographische Befunde bei materno-fetalen Infektionen. Ther Umschau 2008; 65: 667\u201374","DOI":"10.1024\/0040-5930.65.11.667"},{"key":"10.3238\/arztebl.2019.0435_ref55","doi-asserted-by":"crossref","unstructured":"Jakob E, Reuland MS, Mackensen F, et al.: Uveitis subtypes in a German interdisciplinary uveitis center\u2014analysis of 1916 patients. J Rheumatol 2009; 36: 127\u201336","DOI":"10.3899\/jrheum.080102"},{"key":"10.3238\/arztebl.2019.0435_ref56","doi-asserted-by":"crossref","unstructured":"Butler NJ, Furtado JM, Winthrop KL, Smith JR: Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol 2013; 41: 95\u2013108","DOI":"10.1111\/j.1442-9071.2012.02838.x"},{"key":"10.3238\/arztebl.2019.0435_ref57","doi-asserted-by":"crossref","unstructured":"Demarco AL, Rodrigues Mde L, Figueiredo JF, et al.: Susceptibility to toxoplasmic retinochoroiditis is associated with HLA alleles reported to be implicated with rapid progression to AIDS. Dis Markers 2012; 33: 309\u201312","DOI":"10.1155\/2012\/612030"},{"key":"10.3238\/arztebl.2019.0435_ref58","doi-asserted-by":"crossref","unstructured":"Grigg ME, Ganatra J, Boothroyd JC, Margolis TP: Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 2001; 184: 633\u20139","DOI":"10.1086\/322800"},{"key":"10.3238\/arztebl.2019.0435_ref59","doi-asserted-by":"crossref","unstructured":"Derouin F, Pelloux H: Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089\u2013101","DOI":"10.1111\/j.1469-0691.2008.02091.x"},{"key":"10.3238\/arztebl.2019.0435_ref60","doi-asserted-by":"crossref","unstructured":"Weiss LM, Dubey JP: Toxoplasmosis: a history of clinical observations. Int J Parasitol 2009; 39: 895\u2013901","DOI":"10.1016\/j.ijpara.2009.02.004"},{"key":"10.3238\/arztebl.2019.0435_ref61","doi-asserted-by":"crossref","unstructured":"Holec-Gasior L: Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vaccine Immunol 2013; 20: 1343\u201351","DOI":"10.1128\/CVI.00117-13"},{"key":"10.3238\/arztebl.2019.0435_ref62","doi-asserted-by":"crossref","unstructured":"Reiter-Owona I: Laboratory diagnosis of toxoplasmosis \u2013 possibilities and limitations. J Lab Med 2005; 29: 439\u201345","DOI":"10.1515\/JLM.2005.060"},{"key":"10.3238\/arztebl.2019.0435_ref63","doi-asserted-by":"crossref","unstructured":"Lebech M, Joynson DH, Seitz HM, et al.: Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996; 15: 799\u2013805","DOI":"10.1007\/BF01701522"},{"key":"10.3238\/arztebl.2019.0435_ref64","doi-asserted-by":"crossref","unstructured":"Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H: Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001; 97: 296\u2013300","DOI":"10.1097\/00006250-200102000-00024"},{"key":"10.3238\/arztebl.2019.0435_ref65","doi-asserted-by":"crossref","unstructured":"Connolly MP, Haitsma G, Hernandez AV, Vidal JE: Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole. Pathog Glob Health 2017; 111: 327\u201331","DOI":"10.1080\/20477724.2017.1377974"},{"key":"10.3238\/arztebl.2019.0435_ref66","doi-asserted-by":"crossref","unstructured":"Fernandes Felix JP, Cavalcanti Lira RP, Cosimo AB, Cardeal da Costa RL, Nascimento MA, Leite Arieta CE: Trimethoprim-Sulfamethoxazole versus placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences: a three-year follow-up. Am J Ophthalmol 2016; 170: 176\u201382","DOI":"10.1016\/j.ajo.2016.08.003"},{"key":"10.3238\/arztebl.2019.0435_ref67","doi-asserted-by":"crossref","unstructured":"Opsteegh M, Kortbeek TM, Havelaar AH, van der Giessen JW: Intervention strategies to reduce human Toxoplasma gondii disease burden. Clin Infect Dis 2015; 60: 101\u20137","DOI":"10.1093\/cid\/ciu721"},{"key":"10.3238\/arztebl.2019.0435_ref68","unstructured":"Bundeszentrum f\u00fcr Ern\u00e4hrung: Listeriose und Toxoplasmose \u2013 Sicher essen in der Schwangerschaft. 2017. www.ble-medienservice.de\/0346\/listeriose-und-toxoplasmose-sicher-essen-in-der-schwangerschaft (last accessed on 19 May 2019)."},{"key":"10.3238\/arztebl.2019.0435_ref69","unstructured":"Bundesinstitut f\u00fcr Risikobewertung: Schutz vor Toxoplasmose. Verbrauchertipp 2017. https:\/\/mobil.bfr.bund.de\/cm\/350\/verbrauchertipps_schutz_vor_toxoplasmose.pdf (last accessed on\u00a019 May 2019)."},{"key":"10.3238\/arztebl.2019.0435_ref70","doi-asserted-by":"crossref","unstructured":"Verma R, Khanna P: Development of Toxoplasma gondii vaccine: a global challenge. Hum Vaccin Immunother 2013; 9: 291\u20133","DOI":"10.4161\/hv.22474"},{"key":"10.3238\/arztebl.2019.0435_ref71","doi-asserted-by":"crossref","unstructured":"Kullenberg de Gaudry D, Grede N, Motschall E, Lins S: Analysis of German nutrition brochures for pregnant women with evidence-based patient information criteria. Patient Educ Couns 2015; 98: 207\u201312","DOI":"10.1016\/j.pec.2014.10.015"},{"key":"10.3238\/arztebl.2019.0435_ref72","doi-asserted-by":"crossref","unstructured":"Prusa AR, Kasper DC, Sawers L, Walter E, Hayde M, Stillwaggon E: Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving. PLoS Negl Trop Dis 2017; 11: e0005648","DOI":"10.1371\/journal.pntd.0005648"},{"key":"10.3238\/arztebl.2019.0435_ref73","unstructured":"Zylka-Menhorn V. Toxoplasmose-Test Argumente f\u00fcr ein Screening. Dtsch Arztebl 2013; 110: 446"},{"key":"10.3238\/arztebl.2019.0435_ref74","doi-asserted-by":"crossref","unstructured":"Jokelainen P, Murat JB, Nielsen HV: Direct genetic characterization of Toxoplasma gondii from clinical samples from Denmark: not only genotypes II and III. Eur J Clin Microbiol Infect Dis 2018; 37: 579\u201386","DOI":"10.1007\/s10096-017-3152-z"},{"key":"10.3238\/arztebl.2019.0435_ref75","doi-asserted-by":"crossref","unstructured":"Shobab L, Pleyer U, Johnsen J, et al.: Toxoplasma serotype is associated with development of ocular toxoplasmosis. J Infect Dis 2013; 208: 1520\u20138","DOI":"10.1093\/infdis\/jit313"},{"key":"10.3238\/arztebl.2019.0435_ref76","doi-asserted-by":"crossref","unstructured":"Witola WH, Liu SR, Montpetit A, et al.: ALOX12 in human toxoplasmosis. Infect Immun 2014; 82: 2670\u20139","DOI":"10.1128\/IAI.01505-13"},{"key":"10.3238\/arztebl.2019.0435_ref77","doi-asserted-by":"crossref","unstructured":"Witola WH, Mui E, Hargrave A, et al.: NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect Immun 2011; 79: 756\u201366","DOI":"10.1128\/IAI.00898-10"},{"key":"10.3238\/arztebl.2019.0435_ref78","doi-asserted-by":"crossref","unstructured":"Jamieson SE, de Roubaix LA, Cortina-Borja M, et al.: Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One 2008; 3: e2285","DOI":"10.1371\/journal.pone.0002285"},{"key":"10.3238\/arztebl.2019.0435_ref79","doi-asserted-by":"crossref","unstructured":"Takakura A, Tessler HH, Goldstein DA, et al.: Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm 2014; 22: 175\u201382","DOI":"10.3109\/09273948.2013.866256"},{"key":"10.3238\/arztebl.2019.0435_ref80","doi-asserted-by":"crossref","unstructured":"Sauer A, Pfaff AW, Villard O, et al.: Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis. J Infect Dis 2012; 206: 1319\u201329","DOI":"10.1093\/infdis\/jis486"},{"key":"10.3238\/arztebl.2019.0435_ref81","doi-asserted-by":"crossref","unstructured":"Dutra MS, Bela SR, Peixoto-Rangel AL, et al.: Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis 2013; 207: 152\u201363","DOI":"10.1093\/infdis\/jis640"},{"key":"10.3238\/arztebl.2019.0435_ref82","doi-asserted-by":"crossref","unstructured":"Albuquerque MC, Aleixo AL, Benchimol EI, et al.: The IFN-gamma +874T\/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem Inst Oswaldo Cruz 2009; 104: 451\u20135","DOI":"10.1590\/S0074-02762009000300009"},{"key":"10.3238\/arztebl.2019.0435_ref83","doi-asserted-by":"crossref","unstructured":"Peixe RG, Boechat MS, Rangel AL, Rosa RF, Petzl-Erler ML, Bahia-Oliveira LM: Single nucleotide polymorphisms in the interferon gamma gene are associated with distinct types of retinochoroidal scar lesions presumably caused by Toxoplasma gondii infection. Mem Inst Oswaldo Cruz 2014; 109: 99\u2013107","DOI":"10.1590\/0074-0276140539"},{"key":"10.3238\/arztebl.2019.0435_ref84","doi-asserted-by":"crossref","unstructured":"Naranjo-Galvis CA, de-la-Torre A, Mantilla-Muriel LE, et al.: Genetic polymorphisms in cytokine genes in Colombian patients with ocular toxoplasmosis. Infect Immun 2018; 86","DOI":"10.1128\/IAI.00597-17"},{"key":"10.3238\/arztebl.2019.0435_ref85","doi-asserted-by":"crossref","unstructured":"Cordeiro CA, Moreira PR, Andrade MS, et al.: Interleukin-10 gene polymorphism (-1082G\/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci 2008; 49: 1979\u201382","DOI":"10.1167\/iovs.07-1393"},{"key":"10.3238\/arztebl.2019.0435_ref86","doi-asserted-by":"crossref","unstructured":"Cordeiro CA, Moreira PR, Bessa TF, et al.: Interleukin-6 gene polymorphism (-174 G\/C) is associated with toxoplasmic retinochoroiditis. Acta Ophthalmol 2013; 91: e311\u20134","DOI":"10.1111\/aos.12046"},{"key":"10.3238\/arztebl.2019.0435_ref87","unstructured":"Cordeiro CA, Moreira PR, Costa GC, et al.: Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis 2008; 14: 1845\u20139."},{"key":"10.3238\/arztebl.2019.0435_ref88","doi-asserted-by":"crossref","unstructured":"Peixoto-Rangel AL, Miller EN, Castellucci L, et al.: Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz 2009; 104: 1187\u201390","DOI":"10.1590\/S0074-02762009000800019"},{"key":"10.3238\/arztebl.2019.0435_ref89","doi-asserted-by":"crossref","unstructured":"de Faria Junior GM, Ayo CM, de Oliveira AP, et al.: CCR5 chemokine receptor gene polymorphisms in ocular toxoplasmosis. Acta Trop 2018; 178: 276\u201380","DOI":"10.1016\/j.actatropica.2017.12.012"},{"key":"10.3238\/arztebl.2019.0435_ref90","doi-asserted-by":"crossref","unstructured":"Jamieson SE, Peixoto-Rangel AL, Hargrave AC, et al.: Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun 2010; 11: 374\u201383","DOI":"10.1038\/gene.2010.31"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T10:12:09Z","timestamp":1638785529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":90,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2019.0435","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]}}}